share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Jacobs John C

SEC announcement ·  Mar 27 06:15
Summary by Futu AI
John C Jacobs, President and CEO of Novavax Inc. (NVAX), was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Jacobs after the action.
John C Jacobs, President and CEO of Novavax Inc. (NVAX), was reported to have engaged in a transaction involving the company's stock on March 1, 2024. The specific details of the transaction, including the number of shares, nature of the shares, transaction price, and the total value of the shares, were not disclosed in the announcement. The report did not provide information on the number of shares held by Jacobs after the action.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.